BIOLOGICAL EFFECTS OF FIBRINOGEN-FIBRIN DEGRADATION PRODUCTS

被引：20

作者：

LARRIEU, MJ ^{[1
]}

DRAY, L ^{[1
]}

ARDAILLOU, N ^{[1
]}

机构：

[1] HOP BICETRE, INST PATHOL CELLULAIRE, DEPT COAGULATION, 94270 KREMLIN BICETRE, FRANCE

来源：

THROMBOSIS ET DIATHESIS HAEMORRHAGICA | 1975年 / 34卷 / 03期

关键词：

D O I：

10.1055/s-0038-1651461

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：686 / 692

页数：7

共 34 条

[1] PATHOGENESIS OF COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (FIBRINOLYTIC) STATES .2. SIGNIFICANCE, MECHANISM AND CONSEQUENCES OF DEFECTIVE FIBRIN POLYMERIZATION [J].

ALKJAERSIG, N ;

SHERRY, S ;

FLETCHER, AP .

JOURNAL OF CLINICAL INVESTIGATION, 1962, 41 (04) :917-&

[2] PATHOGENESIS OF COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (FIBRINOLYTIC) STATES .3. DEMONSTRATION OF ABNORMAL CLOT STRUCTURE BY ELECTRON MICROSCOPY [J].

BANG, NU ;

SHERRY, S ;

FLETCHER, AP ;

ALKJAERSIG, N .

JOURNAL OF CLINICAL INVESTIGATION, 1962, 41 (04) :935-&

[3]

BUDZYNSK.AZ, 1974, J BIOL CHEM, V249, P2294

[4] HIGH MOLECULAR WEIGHT PRODUCTS OF LATE STAGE OF FIBRINOGEN PROTEOLYSIS BY PLASMIN AND THEIR STRUCTURAL RELATION TO FIBRINOGEN MOLECULE [J].

BUDZYNSKI, AZ ;

STAHL, M ;

KOPEC, M ;

LATALLO, ZS ;

WEGRZYNOWICZ, Z ;

KOWALSKI, E .

BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 147 (02) :313-+

[5] PHARMACOLOGICAL PROPERTIES OF FIBRINOGEN DEGRADATION PRODUCTS [J].

BULUK, K ;

MALOFIEJEW, M .

BRITISH JOURNAL OF PHARMACOLOGY, 1969, 35 (01) :79-+

[6]

CATANZARO A, 1974, J LAB CLIN MED, V83, P458

[7]

CATANZARO A, 1972, P SOC EXP BIOL MED, V139, P1401

[8] INHIBITION OF HUMAN PLATELET-AGGREGATION BY PLASMIN DIGESTS OF HUMAN AND BOVINE FIBRINOGEN PREPARATIONS - ROLE OF CONTAMINATING FACTOR VIII-RELATED MATERIAL [J].

CULASSO, DE ;

DONATI, MB ;

DEGAETAN.G ;

VERMYLEN, J ;

VERSTRAETE, M .

BLOOD, 1974, 44 (02) :169-175

[9]

FLETCHE.AP, 1966, J LAB CLIN MED, V68, P780

[10]

HAYNE OA, 1973, AM J PATHOL, V71, P219

← 1 2 3 4 →